{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T01:44:41Z","timestamp":1767145481808,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/j.clinthera.2008.12.017","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000}}],"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","clinicaltherapeutics.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Clinical Therapeutics"],"published-print":{"date-parts":[[2008,12]]},"DOI":"10.1016\/j.clinthera.2008.12.017","type":"journal-article","created":{"date-parts":[[2009,1,23]],"date-time":"2009-01-23T05:00:35Z","timestamp":1232686835000},"page":"2387-2401","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["RETRACTED: Models for the prediction of mycophenolic acid area under the curve using a limited-sampling strategy and an enzyme multiplied immunoassay technique in chinese patients undergoing liver transplantation"],"prefix":"10.1016","volume":"30","author":[{"given":"Hao","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhidong","family":"Gu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bing","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huarong","family":"Mao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weixia","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qishi","family":"Fan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.clinthera.2008.12.017_bib1","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1517\/14656566.4.12.2325","article-title":"Mycophenolate mofetil in solid-organ transplantation","volume":"4","author":"Srinivas","year":"2003","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/j.clinthera.2008.12.017_bib2","first-page":"925","article-title":"Pharmacokinetics of mycophenolate mofetil (RS61443): A short review","volume":"28","author":"Bullingham","year":"1996","journal-title":"Transplant Proc"},{"issue":"Suppl 1","key":"10.1016\/j.clinthera.2008.12.017_bib3","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1177\/096120330501400102","article-title":"Mechanisms of action of mycophenolate mofetil","volume":"14","author":"Allison","year":"2005","journal-title":"Lupus"},{"key":"10.1016\/j.clinthera.2008.12.017_bib4","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1517\/17425255.1.3.505","article-title":"Mycophenolate mofetil in organ transplantation: Focus on metabolism, safety and tolerability","volume":"1","author":"Shipkova","year":"2005","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/j.clinthera.2008.12.017_bib5","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1093\/ndt\/17.12.2051","article-title":"Tailoring immunosuppressive therapy","volume":"17","author":"Kuypers","year":"2002","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/j.clinthera.2008.12.017_bib6","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1399-0012.1996.tb00662.x","article-title":"Mycophenolate mofetil in liver transplantation","volume":"10","author":"McDiarmid","year":"1996","journal-title":"Clin Transplant"},{"key":"10.1016\/j.clinthera.2008.12.017_bib7","doi-asserted-by":"crossref","first-page":"2671","DOI":"10.1016\/j.transproceed.2004.10.008","article-title":"Impact of combined mycophenolate mofetil and low-dose calcineurin inhibitor therapy on renal function, cardiovascular risk factors, and graft function in liver transplant patients: Preliminary results of an open prospective study","volume":"36","author":"Beckebaum","year":"2004","journal-title":"Transplant Proc"},{"key":"10.1016\/j.clinthera.2008.12.017_bib8","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1097\/01.TP.0000054367.57978.4C","article-title":"Efficacy of mycophenolate mofetil combined with very low-dose cyclosporine microemulsion in longterm liver-transplant patients with renal dysfunction","volume":"76","author":"Cantarovich","year":"2003","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2008.12.017_bib9","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0009-9236(98)90058-3","article-title":"The pharmacokinetic-pharmacodynamic relationship for mycophenolate mofetil in renal transplantation","volume":"64","author":"Hale","year":"1998","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2008.12.017_bib10","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1097\/00007890-200006150-00018","article-title":"The impact of routine mycophenolate mofetil drug moni toring on the treatment of cardiac allograft rejection","volume":"69","author":"Yamani","year":"2000","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2008.12.017_bib11","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1002\/lt.20124","article-title":"Monitoring mycophenolate in liver transplant recipients: Toward a therapeutic range","volume":"10","author":"Tredger","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinthera.2008.12.017_bib12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1097\/01.ftd.0000199358.80013.bd","article-title":"Therapeutic drug monitoring of mycophenolate mofetil in transplantation","volume":"28","author":"van Gelder","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.12.017_bib13","doi-asserted-by":"crossref","first-page":"175","DOI":"10.2165\/00003088-200746020-00005","article-title":"Pharmacokinetics of mycophenolic acid and determination of area under the curve by abbreviated sampling strategy in Chinese liver transplant recipients","volume":"46","author":"Chen","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2008.12.017_bib14","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1002\/lt.21293","article-title":"Validation of limited sampling strategy for the estimation of mycophenolic acid exposure in Chinese adult liver transplant recipients","volume":"13","author":"Hao","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinthera.2008.12.017_bib15","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1097\/01.tp.0000200307.79962.48","article-title":"Sequential determination of pharmacokinetics and pharmaco-dynamics of mycophenolic acid in liver transplant patients treated with mycophenolate mofetil","volume":"81","author":"Brunet","year":"2006","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2008.12.017_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1177\/00912700122010087","article-title":"Pharmacokinetics of mycophenolic acid after mycophenolate mofetil administration in liver transplant patients treated with tacrolimus","volume":"41","author":"Jain","year":"2001","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.12.017_bib17","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1177\/0091270004270145","article-title":"Intraindividual and interindividual variations in the pharmacokinetics of mycophenolic acid in liver transplant patients","volume":"45","author":"Pisupati","year":"2005","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.12.017_bib18","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1016\/j.clinthera.2005.04.004","article-title":"Best single time points as surrogates to the tacrolimus and mycophenolic acid area under the curve in adult liver transplant patients beyond 12 months of transplantation","volume":"27","author":"Mardigyan","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/j.clinthera.2008.12.017_bib19","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00007890-199907270-00018","article-title":"A randomized double-blind, multicenter plasma concentration controlled study of the safety and efficacy of oral mycophenolate mofetil for the prevention of acute rejection after kidney transplantation","volume":"68","author":"van Gelder","year":"1999","journal-title":"Transplantation"},{"key":"10.1016\/j.clinthera.2008.12.017_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1093\/clinchem\/47.1.88","article-title":"Correlation of mycophenolic acid pharmacokinetic parameters with side effects in kidney transplant patients treated with mycophenolate mofetil","volume":"47","author":"Mourad","year":"2001","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2008.12.017_bib21","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/S0009-9236(99)70012-3","article-title":"The kinetics of mycophenolic acid and its glucuronide metabolite in adult kidney transplant recipients","volume":"66","author":"Johnson","year":"1999","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2008.12.017_bib22","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1097\/00007691-200004000-00005","article-title":"Limited sampling strategy for mycophenolic acid area under the curve","volume":"22","author":"Filler","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.12.017_bib23","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1093\/clinchem\/48.9.1497","article-title":"Limited sampling strategy for the estimation of mycophenolic acid area under the curve in adult renal transplant patients treated with concomitant tacrolimus","volume":"48","author":"Pawinski","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/j.clinthera.2008.12.017_bib24","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00007691-200002000-00004","article-title":"Pharmacolkinetic and metabolic investigations of mycophenolic acid in pediatric patients after renal transplantation: Implications for therapeutic drug monitoring. German Study Group on Mycophenolate Mofetil Therapy in Pediatric Renal Transplant Recipients [published correction appears in Ther Drug Monit. 2000;22:500]","volume":"22","author":"Oellerich","year":"2000","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.12.017_bib25","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1214\/aos\/1176345154","article-title":"A note on optimal subset selection procedures","volume":"8","author":"Gupta","year":"1980","journal-title":"Ann Stat"},{"key":"10.1016\/j.clinthera.2008.12.017_bib26","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2165\/00003088-200746030-00003","article-title":"Are population pharmacokinetic and\/or pharmacodynamic models adequately evaluated? A survey of the literature from 2002 to 2004","volume":"46","author":"Brendel","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.clinthera.2008.12.017_bib27","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/lt.20125","article-title":"Therapeutic monitoring of mycophenolic acid in liver transplant patients","volume":"10","author":"Venkataramanan","year":"2004","journal-title":"Liver Transpl"},{"key":"10.1016\/j.clinthera.2008.12.017_bib28","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/S0009-9120(98)00056-3","article-title":"Opportunities for therapeutic monitoring of mycophenolate mofetil dose in renal transplantation suggested by the pharmacokinetic\/pharmacodynamic relationship for mycophenolic acid and suppression of rejection","volume":"31","author":"Nicholls","year":"1998","journal-title":"Clin Biochem"},{"key":"10.1016\/j.clinthera.2008.12.017_bib29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00228-001-0389-2","article-title":"Simultaneous estimation of cyclosporin and mycophenolic acid areas under the curve in stable renal transplant patients using a limited sampling strategy","volume":"57","author":"Le Guellec","year":"2002","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/j.clinthera.2008.12.017_bib30","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1097\/01.ftd.0000159784.25872.f6","article-title":"Population pharmacokinetics of mycophenolic acid in kidney trans plant pediatric and adolescent patients","volume":"27","author":"Payen","year":"2005","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.12.017_bib31","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1046\/j.1600-6143.2005.00779.x","article-title":"Cyclosporine interacts with mycophenolic acid by inhibiting the multidrug resistance-associated protein 2","volume":"5","author":"Hesselink","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/j.clinthera.2008.12.017_bib32","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1097\/00007691-200104000-00005","article-title":"Comparison of the effects of tacrolimus and cyclosporine on the pharma cokinetics of mycophenolic acid","volume":"23","author":"van Gelder","year":"2001","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.12.017_bib33","first-page":"439","article-title":"Comparison of the Bayesian approach and a limited sampling model for the estimation of AUC and Cmax: A computer simulation analysis","volume":"37","author":"Mahmood","year":"1999","journal-title":"Int J Clin Pharmacol Ther"},{"key":"10.1016\/j.clinthera.2008.12.017_bib34","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/01.ftd.0000211810.19935.44","article-title":"Beyond cyclosporine: A systematic review of limited sampling strategies for other immunosuppressants","volume":"28","author":"Ting","year":"2006","journal-title":"Ther Drug Monit"},{"key":"10.1016\/j.clinthera.2008.12.017_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1214\/aos\/1176344552","article-title":"Bootstrap methods: Another look at the jackknife","volume":"7","author":"Efron","year":"1979","journal-title":"Ann Stat"},{"key":"10.1016\/j.clinthera.2008.12.017_bib36","doi-asserted-by":"crossref","first-page":"458","DOI":"10.2133\/dmpk.21.458","article-title":"Histogram analysis of pharmacokinetic parameters by bootstrap resampling from onepoint sampling data in animal experiments","volume":"21","author":"Takemoto","year":"2006","journal-title":"Drug Metab Pharmacokinet"}],"updated-by":[{"DOI":"10.1016\/j.clinthera.2008.12.017","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2008,12,1]],"date-time":"2008-12-01T00:00:00Z","timestamp":1228089600000}},{"DOI":"10.1016\/j.clinthera.2025.08.008","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000}}],"container-title":["Clinical Therapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0149291808004529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,8,8]],"date-time":"2025-08-08T06:39:04Z","timestamp":1754635144000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0149291808004529"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2008,12]]}},"alternative-id":["S0149291808004529"],"URL":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.017","relation":{},"ISSN":["0149-2918"],"issn-type":[{"value":"0149-2918","type":"print"}],"subject":[],"published":{"date-parts":[[2008,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Models for the prediction of mycophenolic acid area under the curve using a limited-sampling strategy and an enzyme multiplied immunoassay technique in chinese patients undergoing liver transplantation","name":"articletitle","label":"Article Title"},{"value":"Clinical Therapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.clinthera.2008.12.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2008 Excerpta Medica Inc. All rights reserved. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]}}